High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman’s Disease
New England Journal of Medicine · 2024
DOI: 10.1056/nejmoa2313398 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Siawosh K Eskandari und 8 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Metabolic Diseases, Beatrix Children's Hospital (S.K.E., F.B., F.J.S., C.M.A.L.), and the Department of Surgery (S.K.E.), Univ…. Hauptthemen laut MEDLINE: Dietary Fats, Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplantation, Immunologic Factors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Department of Metabolic Diseases, Beatrix Children's Hospital (S.K.E., F.B., F.J.S., C.M.A.L.), and the Department of Surgery (S.K.E.), University Medical Center (UMC) Groningen, Groningen, the Division of Pedi…
ORCID-Profile: Siawosh K Eskandari
Zitieren
APA
Eskandari, S. K., Revenich, E. G. M., Pot, D. J., de Boer, F., Bierings, M., van Spronsen, F. J., van Hasselt, P. M., Lindemans, C. A., & Lubout, C. M. A. (2024). High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman’s Disease. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2313398
Vancouver
Eskandari SK, Revenich EGM, Pot DJ, de Boer F, Bierings M, van Spronsen FJ, et al. High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman’s Disease. New England Journal of Medicine. 2024. doi:10.1056/nejmoa2313398
BibTeX
@article{Eskandari2024,
author = {Eskandari, Siawosh K and Revenich, Elisabeth G M and Pot, Dirk J and de Boer, Foekje and Bierings, Marc and van Spronsen, Francjan J and van Hasselt, Peter M and Lindemans, Caroline A and Lubout, Charlotte M A},
title = {High-Dose ERT, Rituximab, and Early HSCT in an Infant with Wolman’s Disease},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmoa2313398}
}
EUVIMED